Items where authors include "Parker, C"

Article

Dearnaley, D, Hinder, V, Hijab, A et al. (26 more authors) (2022) Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. The Lancet Oncology. ISSN 1470-2045

Prescott, M, Lilley-Kelly, A, Cundill, B orcid.org/0000-0002-3648-820X et al. (15 more authors) (2021) Home-based Extended Rehabilitation for Older people (HERO): study protocol for an individually randomised controlled multi-centre trial to determine the clinical and cost-effectiveness of a home-based exercise intervention for older people with frailty as extended rehabilitation following acute illness or injury, including embedded process evaluation. Trials, 22 (1). 783. ISSN 1745-6215

Eckert, C, Parker, C orcid.org/0000-0002-3826-2554, Moorman, AV et al. (16 more authors) (2021) Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. European Journal of Cancer, 151. pp. 175-189. ISSN 0959-8049

Heaven, A, Bower, P, Cundill, B orcid.org/0000-0002-3648-820X et al. (13 more authors) (2020) Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18. Pilot and Feasibility Studies, 6 (1). 56. ISSN 2055-5784

Parker, C orcid.org/0000-0002-3826-2554, Krishnan, S, Hamadeh, L et al. (8 more authors) (2019) Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial. The Lancet Haematology, 6 (4). E204-E216. ISSN 2352-3026

Johnson, SM, Dempsey, C, Parker, C orcid.org/0000-0002-3826-2554 et al. (3 more authors) (2017) Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton. JOURNAL OF EXTRACELLULAR VESICLES, 6 (1). 1294339. ISSN 2001-3078

Liu, J, Masurekar, A, Johnson, S et al. (13 more authors) (2015) Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia. Oncotarget, 6 (40). pp. 43048-43064. ISSN 1949-2553

Masurekar, A, Fong, C, Hussain, A et al. (7 more authors) (2014) The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial. Blood Cancer Journal, 4. e203. ISSN 2044-5385

Krishnan, S, Wade, R, Moorman, AV et al. (7 more authors) (2010) Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985–2001. Leukemia, 24 (2). pp. 450-459. ISSN 0887-6924

Parker, C orcid.org/0000-0002-3826-2554, Rampaul, RS, Pinder, SE et al. (6 more authors) (2001) E-cadherin as a prognostic indicator in primary breast cancer. British Journal of Cancer, 85 (12). pp. 1958-1963. ISSN 0007-0920

Conference or Workshop Item

Parker, C, Hartley, S orcid.org/0000-0003-2346-9461, Holland, M et al. (5 more authors) (2019) Defining clusters in primary care: managing blinding and contamination. In: 5th International Clinical Trials Methodology Conference (ICTMC 2019), 06-09 Oct 2019, Brighton, UK.

Parker, C, Hartley, S orcid.org/0000-0003-2346-9461, Holland, M et al. (3 more authors) (2019) Use of electronic routine screening tools to identify clinical trial participants: case of the eFI. In: 5th International Clinical Trials Methodology Conference (ICTMC 2019), 06-09 Oct 2019, Brighton, UK.

Proceedings Paper

Gill, MD, Bramble, M, Hull, M et al. (7 more authors) (2013) Screen-detected colorectal cancers are associated with an improved outcome when compared with interval cancers when matched for stage. In: Gut. British Society of Gastroenterology Annual General Meeting, 24-27 Jun 2013, Glasgow, UK. BMJ Publishing Group , A38 .